Parenteral feeding and intensive insulin therapy

Critical Care Medicine

Volumn 38, Issue 9, 2010, Pages 1922-

  Bistrian, Bruce Ryan ^a  

^a BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSE; ANTIDIABETIC AGENT; GLUCOSE BLOOD LEVEL; INSULIN;

ENTERIC FEEDING; GLUCOSE BLOOD LEVEL; HUMAN; HYPOGLYCEMIA; INSULIN TREATMENT; INTENSIVE CARE; INTENSIVE CARE UNIT; INTERMETHOD COMPARISON; LETTER; MORTALITY; PARENTERAL NUTRITION; PRIORITY JOURNAL; ANALYSIS; COHORT ANALYSIS;

BLOOD GLUCOSE; COHORT STUDIES; HUMANS; HYPOGLYCEMIC AGENTS; INSULIN; PARENTERAL NUTRITION;

EID: 77956206296     PISSN: 00903493     EISSN: 15300293     Source Type: Journal    
DOI: 10.1097/CCM.0b013e3181e4b637     Document Type: Letter

References (5)

1. Meyfroidt G, Keenan DM, Wang X, et al: Dynamic characteristics of blood glucose time series during the course of critical illness: Effects of intensive insulin therapy and relative association with mortality. Crit Care Med 2010; 38:1021-1029.
2. Krinsley JS: Glycemic variability in critical illness and the end of Chapter. Crit Care Med 2010; 38:1206-1208.
3. Van den Berghe G, Wouters PJ, Bouillon R, et al: Outcome benefit of intensive insulin therapy in the critically ill: Insulin dose versus glycemic control. Crit Care Med 2003; 31: 359-366.
4. Van den Berghe G, Wilmer A, Hermans G, et al: Intensive insulin therapy in the medical ICU. N Engl J Med 2006; 354:449-461.
5. Bistrian BR: Tight glucose control in critically ill adults. JAMA 2008; 300:2726